With 55% ownership, Hikma Pharmaceuticals PLC (LON:HIK) boasts of strong institutional backing
Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to their trading actions 50% of the business is held by the top 13 shareholders Insider...